These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30085829)
1. Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives. Wright N; Rida P; Rakha E; Agboola A; Aneja R J Glob Oncol; 2018 Jul; 4():1-20. PubMed ID: 30085829 [TBL] [Abstract][Full Text] [Related]
2. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians. Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer. Hercules SM; Liu X; Bassey-Archibong BBI; Skeete DHA; Smith Connell S; Daramola A; Banjo AA; Ebughe G; Agan T; Ekanem IO; Udosen J; Obiorah C; Ojule AC; Misauno MA; Dauda AM; Egbujo EC; Hercules JC; Ansari A; Brain I; MacColl C; Xu Y; Jin Y; Chang S; Carpten JD; Bédard A; Pond GR; Blenman KRM; Manojlovic Z; Daniel JM Cancer Causes Control; 2022 Jun; 33(6):831-841. PubMed ID: 35384527 [TBL] [Abstract][Full Text] [Related]
4. Triple-negative breast cancers: Are they always different from nontriple-negative breast cancers? An experience from a tertiary center in India. ; Parshad R; Kazi M; Seenu V; Mathur S; Dattagupta S; Haresh KP Indian J Cancer; 2017; 54(4):658-663. PubMed ID: 30082553 [TBL] [Abstract][Full Text] [Related]
5. Kaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women. Bassey-Archibong BI; Hercules SM; Rayner LGA; Skeete DHA; Smith Connell SP; Brain I; Daramola A; Banjo AAF; Byun JS; Gardner K; Dushoff J; Daniel JM Cancer Causes Control; 2017 Nov; 28(11):1295-1304. PubMed ID: 28887687 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer. Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835 [TBL] [Abstract][Full Text] [Related]
7. Triple-negative Breast Cancer (TNBC) and Its Luminal Androgen Receptor (LAR) Subtype: A Clinicopathologic Review of Cases in a University Hospital in Northwestern Nigeria. Liman AA; Kabir B; Abubakar M; Abdullahi S; Ahmed SA; Shehu SM Niger J Clin Pract; 2022 Jan; 25(1):97-104. PubMed ID: 35046202 [TBL] [Abstract][Full Text] [Related]
8. Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience. Der EM; Gyasi RK; Tettey Y; Edusei L; Bayor MT; Jiagge E; Gyakobo M; Merajver SD; Newman LA Breast J; 2015; 21(6):627-33. PubMed ID: 26547900 [TBL] [Abstract][Full Text] [Related]
9. Triple negative breast cancer: looking for the missing link between biology and treatments. Palma G; Frasci G; Chirico A; Esposito E; Siani C; Saturnino C; Arra C; Ciliberto G; Giordano A; D'Aiuto M Oncotarget; 2015 Sep; 6(29):26560-74. PubMed ID: 26387133 [TBL] [Abstract][Full Text] [Related]
10. Time will tell: Circadian clock dysregulation in triple negative breast cancer. Rida P; Syed MI; Aneja R Front Biosci (Schol Ed); 2019 Mar; 11(1):178-192. PubMed ID: 30844743 [TBL] [Abstract][Full Text] [Related]
11. Triple-Negative Breast Cancer, Stem Cells, and African Ancestry. Jiagge E; Chitale D; Newman LA Am J Pathol; 2018 Feb; 188(2):271-279. PubMed ID: 29137951 [TBL] [Abstract][Full Text] [Related]
12. Racial Disparity and Triple-Negative Breast Cancer in African-American Women: A Multifaceted Affair between Obesity, Biology, and Socioeconomic Determinants. Siddharth S; Sharma D Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30558195 [TBL] [Abstract][Full Text] [Related]
13. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients. Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291 [TBL] [Abstract][Full Text] [Related]
14. Limited family structure and triple-negative breast cancer (TNBC) subtype as predictors of BRCA mutations in a genetic counseling cohort of early-onset sporadic breast cancers. Zugazagoitia J; Pérez-Segura P; Manzano A; Blanco I; Vega A; Custodio A; Teulé A; Fachal L; Martínez B; González-Sarmiento R; Cruz-Hernández JJ; Chirivella I; Garcés V; Garre P; Romero A; Caldés T; Díaz-Rubio E; de la Hoya M Breast Cancer Res Treat; 2014 Nov; 148(2):415-21. PubMed ID: 25342642 [TBL] [Abstract][Full Text] [Related]
15. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion. Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366 [TBL] [Abstract][Full Text] [Related]
16. Translational Epidemiology: Genetic Ancestry in Breast Cancer: What Is the Role of Genetic Ancestry and Socioeconomic Status in Triple-Negative Breast Cancer? Goel N; Hernandez A; Merchant N; Rebbeck T Adv Surg; 2023 Sep; 57(1):1-14. PubMed ID: 37536846 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity. Martini R; Newman L; Davis M Clin Exp Metastasis; 2022 Feb; 39(1):7-14. PubMed ID: 33950410 [TBL] [Abstract][Full Text] [Related]
18. Alarming Burden of Triple-Negative Breast Cancer in India. Thakur KK; Bordoloi D; Kunnumakkara AB Clin Breast Cancer; 2018 Jun; 18(3):e393-e399. PubMed ID: 28801156 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry. Brewster AM; Chavez-MacGregor M; Brown P Lancet Oncol; 2014 Dec; 15(13):e625-e634. PubMed ID: 25456381 [TBL] [Abstract][Full Text] [Related]
20. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer. Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]